Neuronetics (STIM) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

STIM Stock Forecast

Neuronetics stock forecast is as follows: an average price target of $8.00 (represents a 440.54% upside from STIM’s last price of $1.48) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

STIM Price Target

The average price target for Neuronetics (STIM) is $8.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 440.54% upside from STIM's last price of $1.48.

STIM Analyst Ratings

Buy

According to 3 Wall Street analysts, Neuronetics's rating consensus is 'Buy'. The analyst rating breakdown for STIM stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Neuronetics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 08, 2022	Adam Maeder	Piper Sandler	$8.00	$3.71	115.63%	440.54%

The latest Neuronetics stock forecast, released on Nov 08, 2022 by Adam Maeder from Piper Sandler, set a price target of $8.00, which represents a 115.63% increase from the stock price at the time of the forecast ($3.71), and a 440.54% increase from STIM last price ($1.48).

Neuronetics Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$1.48	$1.48	$1.48
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Neuronetics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Neuronetics's last price of $1.48. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 14, 2024	JMP Securities	Outperform	Outperform	Hold
Aug 12, 2024	William Blair	Outperform	Market Perform	Downgrade
May 14, 2024	William Blair		Outperform	Upgrade
Jan 09, 2023	Piper Sandler	Overweight	Overweight	Hold

Neuronetics's last stock rating was published by JMP Securities on Aug 14, 2024. The company gave STIM a "Outperform" rating, the same as its previous rate.

Neuronetics Financial Forecast

Neuronetics Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$20.31M	$17.88M	$17.61M	$15.54M	$18.20M	$16.50M	$16.33M	$14.18M	-	$13.80M	$14.20M	$12.29M	$15.58M	$12.45M	$9.74M	$11.48M	$17.36M	$16.00M
Avg Forecast	$21.40M	$21.10M	$21.20M	$21.30M	$20.70M	$19.41M	$18.49M	$18.37M	$18.98M	$19.14M	$18.65M	$17.12M	$19.85M	$17.58M	$17.36M	$15.18M	$16.82M	$15.02M	$15.46M	$13.46M	$14.44M	$14.10M	$14.72M	$11.57M	$14.41M	$11.23M	$8.22M	$13.03M	$16.95M	$16.19M
High Forecast	$21.97M	$21.67M	$21.77M	$21.87M	$21.25M	$19.93M	$18.99M	$19.02M	$19.21M	$19.26M	$18.65M	$17.12M	$19.97M	$18.05M	$17.83M	$15.59M	$17.27M	$15.02M	$15.46M	$13.46M	$14.44M	$14.10M	$14.72M	$11.57M	$14.41M	$11.23M	$8.22M	$13.03M	$16.95M	$16.19M
Low Forecast	$20.67M	$20.38M	$20.48M	$20.57M	$19.99M	$18.75M	$17.86M	$17.72M	$18.76M	$19.01M	$18.65M	$17.12M	$19.72M	$16.98M	$16.77M	$14.66M	$16.25M	$15.02M	$15.46M	$13.46M	$14.44M	$14.10M	$14.72M	$11.57M	$14.41M	$11.23M	$8.22M	$13.03M	$16.95M	$16.19M
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	7	5	5	9	6	4	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	1.02%	1.01%	1.02%	1.08%	1.10%	1.06%	1.05%	-	0.98%	0.96%	1.06%	1.08%	1.11%	1.19%	0.88%	1.02%	0.99%

Neuronetics's average Quarter revenue forecast for Mar 24 based on 1 analysts is $17.12M, with a low forecast of $17.12M, and a high forecast of $17.12M. STIM's average Quarter revenue forecast represents a -15.71% decrease compared to the company's last Quarter revenue of $20.31M (Dec 23).

Neuronetics EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	7	5	5	9	6	4	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-4.43M	$-8.87M	$-7.35M	$-8.75M	$-7.08M	$-6.16M	$-9.42M	$-9.54M	$-9.58M	$-6.94M	$-6.28M	$-6.62M	$-6.35M	$-2.21M	$-6.55M	$-10.79M	$-6.35M	$-5.63M
Avg Forecast	$-9.14M	$-9.01M	$-9.06M	$-9.10M	$-8.84M	$-8.29M	$-7.90M	$-7.85M	$-8.11M	$-8.18M	$-7.97M	$-7.32M	$-8.48M	$-7.51M	$-7.42M	$-6.49M	$-7.19M	$-6.51M	$-6.70M	$-5.83M	$-6.26M	$-6.11M	$-6.38M	$-6.62M	$-6.24M	$-4.87M	$-3.56M	$-6.90M	$-7.34M	$-7.02M
High Forecast	$-8.83M	$-8.71M	$-8.75M	$-8.79M	$-8.54M	$-8.01M	$-7.63M	$-7.57M	$-8.02M	$-8.12M	$-7.97M	$-7.32M	$-8.42M	$-7.25M	$-7.16M	$-6.26M	$-6.94M	$-6.51M	$-6.70M	$-5.83M	$-6.26M	$-6.11M	$-6.38M	$-5.29M	$-6.24M	$-4.87M	$-3.56M	$-5.52M	$-7.34M	$-7.02M
Low Forecast	$-9.39M	$-9.26M	$-9.30M	$-9.34M	$-9.08M	$-8.51M	$-8.11M	$-8.12M	$-8.21M	$-8.23M	$-7.97M	$-7.32M	$-8.53M	$-7.71M	$-7.62M	$-6.66M	$-7.38M	$-6.51M	$-6.70M	$-5.83M	$-6.26M	$-6.11M	$-6.38M	$-7.94M	$-6.24M	$-4.87M	$-3.56M	$-8.29M	$-7.34M	$-7.02M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.52%	1.18%	0.99%	1.35%	0.98%	0.95%	1.41%	1.64%	1.53%	1.14%	0.98%	1.00%	1.02%	0.45%	1.84%	1.56%	0.86%	0.80%

undefined analysts predict STIM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Neuronetics's previous annual EBITDA (undefined) of $NaN.

Neuronetics Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	7	5	5	9	6	4	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-5.38M	$-9.39M	$-4.90M	$-11.13M	$-8.85M	$-7.76M	$-11.05M	$-11.54M	$-7.63M	$-8.15M	$-7.53M	$-7.88M	$-3.66M	$-3.42M	$-7.76M	$-12.61M	$-7.55M	$-6.87M
Avg Forecast	$-3.03M	$-3.03M	$-3.03M	$-3.03M	$-3.40M	$-4.94M	$-5.78M	$-6.01M	$-7.34M	$-6.93M	$-8.15M	$-9.37M	$-7.85M	$-9.38M	$-10.52M	$-11.73M	$-11.50M	$-12.69M	$-12.35M	$-12.04M	$-9.52M	$-9.09M	$-7.21M	$-7.88M	$-7.24M	$-8.47M	$-15.54M	$-8.07M	$-13.26M	$-12.86M
High Forecast	$-2.89M	$-2.89M	$-2.89M	$-2.89M	$-3.25M	$-4.72M	$-5.52M	$-5.19M	$-6.49M	$-6.63M	$-7.79M	$-8.95M	$-7.55M	$-8.97M	$-10.05M	$-11.21M	$-10.99M	$-12.69M	$-12.35M	$-12.04M	$-9.52M	$-9.09M	$-7.21M	$-6.30M	$-7.24M	$-8.47M	$-15.54M	$-6.46M	$-13.26M	$-12.86M
Low Forecast	$-3.13M	$-3.13M	$-3.13M	$-3.13M	$-3.52M	$-5.11M	$-5.98M	$-6.83M	$-7.90M	$-7.17M	$-8.43M	$-9.70M	$-8.15M	$-9.71M	$-10.88M	$-12.14M	$-11.90M	$-12.69M	$-12.35M	$-12.04M	$-9.52M	$-9.09M	$-7.21M	$-9.46M	$-7.24M	$-8.47M	$-15.54M	$-9.69M	$-13.26M	$-12.86M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.68%	1.00%	0.47%	0.95%	0.77%	0.61%	0.89%	0.96%	0.80%	0.90%	1.04%	1.00%	0.51%	0.40%	0.50%	1.56%	0.57%	0.53%

Neuronetics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. STIM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Neuronetics SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	7	5	5	9	6	4	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$17.99M	$18.48M	$17.76M	$18.51M	$18.40M	$18.03M	$20.04M	$19.03M	$6.33M	$16.26M	$15.72M	$14.66M	$12.36M	$10.26M	$12.16M	$16.01M	$15.83M	$14.65M
Avg Forecast	$22.76M	$22.44M	$22.55M	$22.66M	$22.01M	$20.64M	$19.67M	$19.54M	$20.19M	$20.35M	$19.83M	$18.21M	$21.11M	$18.70M	$18.47M	$16.15M	$17.89M	$15.89M	$16.35M	$14.24M	$15.27M	$14.91M	$15.57M	$12.24M	$15.24M	$11.88M	$8.70M	$10.25M	$17.93M	$17.13M
High Forecast	$23.37M	$23.04M	$23.15M	$23.26M	$22.60M	$21.20M	$20.20M	$20.23M	$20.43M	$20.48M	$19.83M	$18.21M	$21.24M	$19.20M	$18.96M	$16.58M	$18.37M	$15.89M	$16.35M	$14.24M	$15.27M	$14.91M	$15.57M	$12.24M	$15.24M	$11.88M	$8.70M	$12.30M	$17.93M	$17.13M
Low Forecast	$21.98M	$21.68M	$21.78M	$21.88M	$21.26M	$19.94M	$19.00M	$18.85M	$19.96M	$20.22M	$19.83M	$18.21M	$20.98M	$18.06M	$17.84M	$15.59M	$17.28M	$15.89M	$16.35M	$14.24M	$15.27M	$14.91M	$15.57M	$12.24M	$15.24M	$11.88M	$8.70M	$8.20M	$17.93M	$17.13M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.85%	0.99%	0.96%	1.15%	1.03%	1.14%	1.23%	1.34%	0.41%	1.09%	1.01%	1.20%	0.81%	0.86%	1.40%	1.56%	0.88%	0.86%

Neuronetics's average Quarter SG&A projection for Mar 24 is $18.21M, based on 1 Wall Street analysts, with a range of $18.21M to $18.21M. The forecast indicates a 1.23% rise compared to STIM last annual SG&A of $17.99M (Dec 23).

Neuronetics EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	7	5	5	9	6	4	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.19	$-0.33	$-0.17	$-0.40	$-0.33	$-0.29	$-0.41	$-0.43	$-0.29	$-0.31	$-0.29	$-0.31	$-0.19	$-0.18	$-0.41	$-0.68	$-0.41	$-0.37
Avg Forecast	$-0.10	$-0.10	$-0.10	$-0.10	$-0.11	$-0.16	$-0.19	$-0.20	$-0.24	$-0.23	$-0.27	$-0.31	$-0.26	$-0.31	$-0.35	$-0.39	$-0.38	$-0.42	$-0.41	$-0.40	$-0.32	$-0.30	$-0.24	$-0.31	$-0.24	$-0.28	$-0.52	$-0.50	$-0.44	$-0.43
High Forecast	$-0.10	$-0.10	$-0.10	$-0.10	$-0.11	$-0.16	$-0.18	$-0.17	$-0.21	$-0.22	$-0.26	$-0.30	$-0.25	$-0.30	$-0.33	$-0.37	$-0.36	$-0.42	$-0.41	$-0.40	$-0.32	$-0.30	$-0.24	$-0.31	$-0.24	$-0.28	$-0.52	$-0.50	$-0.44	$-0.43
Low Forecast	$-0.10	$-0.10	$-0.10	$-0.10	$-0.12	$-0.17	$-0.20	$-0.23	$-0.26	$-0.24	$-0.28	$-0.32	$-0.27	$-0.32	$-0.36	$-0.40	$-0.39	$-0.42	$-0.41	$-0.40	$-0.32	$-0.30	$-0.24	$-0.31	$-0.24	$-0.28	$-0.52	$-0.50	$-0.44	$-0.43
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.73%	1.06%	0.49%	1.03%	0.87%	0.69%	1.00%	1.07%	0.92%	1.03%	1.21%	1.00%	0.79%	0.64%	0.79%	1.36%	0.93%	0.86%

According to undefined Wall Street analysts, Neuronetics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to STIM previous annual EPS of $NaN (undefined).

Neuronetics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DRIO	DarioHealth	$0.70	$10.75	1435.71%	Buy
STIM	Neuronetics	$1.48	$8.00	440.54%	Buy
BDSX	Biodesix	$1.48	$3.00	102.70%	Buy
SHC	Sotera Health	$13.48	$16.00	18.69%	Buy
XGN	Exagen	$4.71	$5.00	6.16%	Buy

STIM Forecast FAQ

Is Neuronetics a good buy?

Yes, according to 3 Wall Street analysts, Neuronetics (STIM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of STIM's total ratings.

What is STIM's price target?

Neuronetics (STIM) average price target is $8 with a range of $8 to $8, implying a 440.54% from its last price of $1.48. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Neuronetics stock go up soon?

According to Wall Street analysts' prediction for STIM stock, the company can go up by 440.54% (from the last price of $1.48 to the average price target of $8), up by 440.54% based on the highest stock price target, and up by 440.54% based on the lowest stock price target.

Can Neuronetics stock reach $2?

STIM's average twelve months analyst stock price target of $8 supports the claim that Neuronetics can reach $2 in the near future.

What are Neuronetics's analysts' financial forecasts?

Neuronetics's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $76.97M (high $79.18M, low $74.32M), average EBITDA is $-32.882M (high $-31.75M, low $-33.829M), average net income is $-20.142M (high $-18.694M, low $-21.454M), average SG&A $81.87M (high $84.22M, low $79.05M), and average EPS is $-0.665 (high $-0.618, low $-0.709). STIM's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $85M (high $87.28M, low $82.1M), average EBITDA is $-36.313M (high $-35.074M, low $-37.285M), average net income is $-12.107M (high $-11.57M, low $-12.528M), average SG&A $90.41M (high $92.83M, low $87.32M), and average EPS is $-0.4 (high $-0.382, low $-0.414).

Did the STIM's actual financial results beat the analysts' financial forecasts?

Based on Neuronetics's last annual report (Dec 2023), the company's revenue was $71.35M, beating the average analysts forecast of $69.97M by 1.97%. Apple's EBITDA was $-30.554M, beating the average prediction of $-29.892M by 2.21%. The company's net income was $-30.189M, missing the average estimation of $-39.48M by -23.53%. Apple's SG&A was $72.74M, missing the average forecast of $74.42M by -2.26%. Lastly, the company's EPS was $-1.05, missing the average prediction of $-1.304 by -19.50%. In terms of the last quarterly report (Dec 2023), Neuronetics's revenue was $20.31M, beating the average analysts' forecast of $19.85M by 2.33%. The company's EBITDA was $-4.427M, missing the average prediction of $-8.481M by -47.80%. Neuronetics's net income was $-5.377M, missing the average estimation of $-7.851M by -31.51%. The company's SG&A was $17.99M, missing the average forecast of $21.11M by -14.79%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.259 by -26.75%